EQUITY - Embodiment, social ineQualities, lifecoUrse epidemiology, cancer and chronIc diseases, intervenTions, methodologY
Equipe constitutive du CERPOP, UMR1295, unité mixte INSERM - Université Toulouse III Paul Sabatier
Laëtitia DAUBISSE-MARLIAC •  chercheure



2023
  1. Demuru E, Rossi S, Ventura L, Dal Maso L, Guzzinati S, Katalinic A, Lamy S, Jooste V, Di Benedetto C, De Angelis R; EUROCARE-6 Working Group (Daubisse-Marliac L.collaborator). Estimating complete cancer prevalence in Europe: validity of alternative vs standard completeness indexes. Front Oncol. 2023 Apr 24;13:1114701. doi: 10.3389/fonc.2023.1114701.
  2. Girardi F, Matz M, Stiller C, You H, Marcos Gragera R, Valkov MY, Bulliard JL, De P, Morrison D, Wanner M, O'Brian DK, Saint-Jacques N, Coleman MP, Allemani C; CONCORD Working Group (Daubisse-Marliac L.collaborator). Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000-2014 (CONCORD-3). Neuro Oncol. 2023 Mar 14;25(3):580-592. doi: 10.1093/neuonc/noac217.
  3. Girardi F, Di Carlo V, Stiller C, Gatta G, Woods RR, Visser O, Lacour B, Tucker TC, Coleman MP, Allemani C; CONCORD Working Group (Daubisse-Marliac L.collaborator). Global survival trends for brain tumors, by histology: Analysis of individual records for 67,776 children diagnosed in 61 countries during 2000-2014 (CONCORD-3). Neuro Oncol. 2023 Mar 14;25(3):593-606. doi: 10.1093/neuonc/noac232.
2022
  1. Assogba ELF, Dumas A, Woronoff AS, Mollévi C, Coutant C, Ladoire S, Desmoulins I, Dabakuyo-Yonli TS; French Network of Cancer Registries (FRANCIM) (Cowppli-Bony A, Daubisse-Marliac L, Grosclaude P collaborators). Cross-sectional nationwide mixed-methods population-based study of living conditions, and identification of sexual and fertility profiles among young women after breast cancer in France: the Candy study protocol. BMJ Open. 2022 Sep 28;12(9):e056834. doi: 10.1136/bmjopen-2021-056834.
  2. Compaoré ZC, Monnet E, Gérazime A, Molinié F, Guizard AV, Delafosse P, Dabakuyo-Yonli TS, Coureau G, Hammas K, Plouvier S, Bara S, Défossez G, Lapôtre-Ledoux B, Daubisse-Marliac L, d'Almeida T, Launoy G, Mansi L, Trétarre B, Woronoff AS. To what extent do age, stage and treatment influence survival after invasive cervical cancer: a French population-based study. Cancer Causes Control. 2022 Mar;33(3):403-415. doi: 10.1007/s10552-021-01536-9.
  3. Daubisse-Marliac L, Grosclaude P, Carulla M, Parada D, Vilardell L, Ameijide A, Marcos-Gragera R, Galceran J. Registration of Urothelial Tumours in Cancer Registries: How to Improve and Make It More Useful? Int J Environ Res Public Health. 2022 Feb 25;19(5):2714. doi: 10.3390/ijerph19052714.
  4. Di Carlo V, Stiller CA, Eisemann N, Bordoni A, Matz M, Curado MP, Daubisse-Marliac L, Valkov M, Bulliard JL, Morrison D, Johnson C, Girardi F, Marcos-Gragera R, Šekerija M, Larønningen S, Sirri E, Coleman MP, Allemani C; CONCORD Working Group. Does the morphology of cutaneous melanoma help explain the international differences in survival? Results from 1,578,482 adults diagnosed during 2000-2014 in 59 countries (CONCORD-3). Br J Dermatol. 2022 Mar 29. doi: 10.1111/bjd.21274. Epub ahead of print.
  5. Galceran J, Parada D, Eden M, Tumino R, Warren AY, Martos C, Neamtiu L, Visser O, Daubisse-Marliac L. The 2022 ENCR Recommendations on recording and reporting of urothelial tumours of the urinary tract. Front Oncol. 2022 Nov 23;12:1046239. doi: 10.3389/fonc.2022.1046239.
  6. Martinez A, Daubisse-Marliac L, Lacaze JL, Pons-Tostivint E, Bauvin E, Delpierre C, Grosclaude P, Lamy S; EvaSein Group. Treatment time interval in breast cancer: A population-based study on the impact of type and number of cancer centres attended. Eur J Cancer Care (Engl). 2022 Nov;31(6):e13654. doi: 10.1111/ecc.13654.
  7. Ssenyonga N, Stiller C, Nakata K, Shalkow J, Redmond S, Bulliard JL, Girardi F, Fowler C, Marcos-Gragera R, Bonaventure A, Saint-Jacques N, Minicozzi P, De P, Rodríguez-Barranco M, Larønningen S, Di Carlo V, Mägi M, Valkov M, Seppä K, Wyn Huws D, Coleman MP, Allemani C; CONCORD Working Group (Daubisse-Marliac L collaborator). Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000-14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries. Lancet Child Adolesc Health. 2022 Jun;6(6):409-431. doi: 10.1016/S2352-4642(22)00095-5.
2021
  1. Baicry F, Molinié F, Plouvier S, Colonna M, Daubisse-Marliac L, Grosclaude P, Trétarre B, Bara S, Lapôtre-Ledoux B, Woronoff AS, Guizard AV, Bouvier V, Troussard X, Marrer E, Klein D, Velten M, Jégu J. What is the most appropriate period to define synchronous cancers? Cancer Epidemiol. 2021 Apr;71(Pt A):101900. doi: 10.1016/j.canep.2021.101900.
  2. Defossez G, Uhry Z, Delafosse P, Dantony E, d'Almeida T, Plouvier S, Bossard N, Bouvier AM, Molinié F, Woronoff AS, Colonna M, Grosclaude P, Remontet L, Monnereau A; French Network of Cancer Registries (FRANCIM) (Daubisse-Marliac L collaborator). Cancer incidence and mortality trends in France over 1990-2018 for solid tumors: the sex gap is narrowing. BMC Cancer. 2021 Jun 24;21(1):726. doi: 10.1186/s12885-021-08261-1.
  3. Foucan AS, Grosclaude P, Bousser V, Bauvin E, Smith D, Andre-Fardeau C, Daubisse-Marliac L, Mathoulin-Pelissier S, Amadeo B, Coureau G. Management of colon cancer patients: A comprehensive analysis of the absence of multidisciplinary team meetings in two French departments. Clin Res Hepatol Gastroenterol. 2021 Mar;45(2):101413. doi: 10.1016/j.clinre.2020.02.020.
  4. Raze T, Lacour B, Cowppli-Bony A, Delafosse P, Velten M, Trétarre B, Defossez G, Hammas K, Woronoff AS, Ganry O, Plouvier S, Coureau G, Guizard AV, Bara S, Monnereau A, Daubisse-Marliac L, Troussard X, D'Almeida T, Baldi I, Bouvier V, Boissel N, Clavel J, Desandes E. Cancer Among Adolescents and Young Adults Between 2000 and 2016 in France: Incidence and Improved Survival. J Adolesc Young Adult Oncol. 2021 Feb;10(1):29-45. doi: 10.1089/jayao.2020.0017.
  5. Xiao D, Guizard AV, Daubisse-Marliac L, Woronoff AS, Trétarre B, Delafosse P, Molinié F, Cowppli-Bony A, Lapôtre-Ledoux B, Bara S, Marrer E, Velten M, Laroche L, Heutte N, Grosclaude P, Joly F. Evaluation of long-term living conditions in patients treated for localised prostate cancer. Eur J Cancer Care (Engl). 2021 Jan;30(1):e13333. doi: 10.1111/ecc.13333.
2020
  1. Bouvier AM, Robaszkiewicz M, Jooste V, Cariou M, Drouillard A, Bouvier V, Nousbaum JB; French Network of Cancer Registries (FRANCIM) (Daubisse-Marliac L collaborator). Trends in incidence of small bowel cancer according to histology: a population-based study. J Gastroenterol. 2020 Feb;55(2):181-188. doi: 10.1007/s00535-019-01636-z.
  2. Foucan AS, Grosclaude P, Bousser V, Bauvin E, Smith D, Andre-Fardeau C, Daubisse-Marliac L, Mathoulin-Pelissier S, Amadeo B, Coureau G. Management of colon cancer patients: A comprehensive analysis of the absence of multidisciplinary team meetings in two French departments.  Clin Res Hepatol Gastroenterol. 2020 Apr 28:S2210-7401(20)30087-5. doi: 10.1016/j.clinre.2020.02.020. Epub ahead of print.
  3. Grosclaude P, Azria D, Guimbaud R, Thibault  S, Daubisse  L, Cartron  G, Renaudie  MJ, Dalbies PA, Delord JP, Bauvin E. Impact du SARS-CoV2 sur la structuration de la prise en charge du cancer : exemple de la tenue des RCP de cancérologie en Occitanie [COVID-19 impact on the cancer care structuration: example of the multidisciplinary team meeting dedicated to oncology in Occitanie] [published online ahead of print, 2020 May 18]. Bull Cancer. 2020;10.1016/j.bulcan.2020.05.001. doi:10.1016/j.bulcan.2020.05.001.
  4. Pons-Tostivint E, Grosclaude P, Daubisse-Marliac L. Reply to Ivica Ratosa et al. Comment on: "Multidisciplinary team meeting and EUSOMA quality indicators in breast cancer care: A French regional multicenter study". Breast. 2020 Oct;53:42. doi: 10.1016/j.breast.2020.06.006.
  5. Raze T, Lacour B, Cowppli-Bony A, Delafosse P, Velten M, Trétarre B, Defossez G, Hammas K, Woronoff  AS, Ganry O, Plouvier S, Coureau G, Guizard AV, Bara S, Monnereau A, Daubisse-Marliac L, Troussard  X, D'Almeida T, Baldi I, Bouvier V, Boissel N, Clavel J, Desandes E. Cancer Among Adolescents and Young Adults Between 2000 and 2016 in France: Incidence and Improved Survival [published online ahead of print, 2020 May 15]. J Adolesc Young Adult Oncol. 2020;10.1089/jayao.2020.0017. doi:10.1089/jayao.2020.0017.
  6. Villers A, Bessaoud F, Trétarre B, Grosclaude P, Malavaud B, Rebillard X, Iborra F, Daubisse L, Malavaud S, Roobol M, Heijnsdijk EA, de Koning HJ, Hugosson J, Rischmann P, Soulié M. Contamination in control group led to no effect of PSA-based screening on prostate cancer mortality at 9 years follow-up: Results of the French section of European Randomized Study of Screening for Prostate Cancer (ERSPC). Prog Urol. 2020 Apr;30(5):252-260. doi: 10.1016/j.purol.2020.02.011.
2019
  1. Cowppli-Bony A, Colonna M, Ligier K, Jooste V, Defossez G, Monnereau A; le Réseau Francim; Réseau des registres de cancer Francim (Daubisse-Marliac L collaborator). [Descriptive epidemiology of cancer in metropolitan France: Incidence, survival and prevalence]. Bull Cancer. 2019 Jul-Aug;106(7-8):617-634. doi: 10.1016/j.bulcan.2018.11.016.
  2. Cowppli-Bony A, Trétarre B, Marrer E, Defossez G, Daubisse-Marliac L, Coureau G, Minicozzi P, Woronoff AS, Delafosse P, Molinié F; FRANCIM network. Compliance with clinical guidelines for breast cancer management: A population-based study of quality-of-care indicators in France. PLoS One. 2019 Oct 23;14(10):e0224275. doi: 10.1371/journal.pone.0224275.
  3. Daubisse-Marliac L, Balardy L, Le Goualher L, Bourgade G, Perrier C, Guimbaud R. Adapter le parcours de soins [Adapting the care pathway]. Soins Gerontol. 2019;24(135):15–18.  doi:10.1016/j.sger.2018.11.004.
  4. Lamy S, Molinié F, Daubisse-Marliac L, Cowppli-Bony A, Ayrault-Piault S, Fournier E, Woronoff AS, Delpierre C, Grosclaude P. Using ecological socioeconomic position (SEP) measures to deal with sample bias introduced by incomplete individual-level measures: inequalities in breast cancer stage at diagnosis as an example. BMC Public Health. 2019 Jul 2;19(1):857. doi: 1186/s12889-019-7220-4.
  5. Matysiak-Budnik T, Jamet P, Ruskoné-Fourmestraux A, de Mascarel A, Velten M, Maynadié M, Woronoff AS, Trétarre B, Marrer E, Delafosse P, Ligier K, Lapôtre Ledoux B, Daubisse L, Bouzid L, Orazio S, Cowppli-Bony A, Monnereau A. Gastric MALT lymphoma in a population-based study in France: clinical features, treatments and survival. Aliment Pharmacol Ther. 2019 Sep;50(6):654-663. doi: 10.1111/apt.15409.
  6. Pons-Tostivint E, Daubisse-Marliac L, Grosclaude P, Oum Sack E, Goddard J, Morel C, Dunet C, Sibrac L, Lagadic C, Bauvin E, Bergé Y, Bernard-Marty C, Vaysse C, Lacaze JLL; EvaSein Group. Multidisciplinary team meeting and EUSOMA quality indicators in breast cancer care: A French regional multicenter study. Breast. 2019 Aug;46:170-177. doi: 10.1016/j.breast.2019.06.001.